DE69031649D1 - Oxoindolderivate - Google Patents

Oxoindolderivate

Info

Publication number
DE69031649D1
DE69031649D1 DE69031649T DE69031649T DE69031649D1 DE 69031649 D1 DE69031649 D1 DE 69031649D1 DE 69031649 T DE69031649 T DE 69031649T DE 69031649 T DE69031649 T DE 69031649T DE 69031649 D1 DE69031649 D1 DE 69031649D1
Authority
DE
Germany
Prior art keywords
lower alkyl
halogen
lower alkoxy
alkyl
benzyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69031649T
Other languages
English (en)
Other versions
DE69031649T2 (de
Inventor
Akihiro - Kawaguchi
Atsushi - Sato
Makoto - Kajitani
Mitsugi Yasumoto
Junji Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69031649D1 publication Critical patent/DE69031649D1/de
Publication of DE69031649T2 publication Critical patent/DE69031649T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69031649T 1989-07-25 1990-07-23 Oxoindolderivate Expired - Fee Related DE69031649T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19182289 1989-07-25
PCT/JP1990/000945 WO1991001306A1 (fr) 1989-07-25 1990-07-23 Derive oxoindole

Publications (2)

Publication Number Publication Date
DE69031649D1 true DE69031649D1 (de) 1997-12-04
DE69031649T2 DE69031649T2 (de) 1998-02-26

Family

ID=16281100

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69031649T Expired - Fee Related DE69031649T2 (de) 1989-07-25 1990-07-23 Oxoindolderivate

Country Status (10)

Country Link
US (1) US5206261A (de)
EP (1) EP0429685B1 (de)
JP (1) JP2739188B2 (de)
KR (1) KR930011300B1 (de)
AT (1) ATE159718T1 (de)
CA (1) CA2037923C (de)
DE (1) DE69031649T2 (de)
DK (1) DK0429685T3 (de)
ES (1) ES2110965T3 (de)
WO (1) WO1991001306A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2051151C1 (ru) * 1992-01-16 1995-12-27 Дзе Дюпон Мерк Фармасьютикал Компани Азотсодержащие гетероциклические производные флуорена
DE69218795T2 (de) * 1992-01-16 1997-07-10 Du Pont Merck Pharma Verbindungen,die neurotransmitter freisetzen,um die lernfähigkeit zu erhöhen
FR2686878B1 (fr) * 1992-01-30 1995-06-30 Sanofi Elf Derives du n-sulfonyl oxo-2 indole, leur preparation, les compositions pharmaceutiques en contenant.
US5849780A (en) * 1992-01-30 1998-12-15 Sanofi 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
US5310935A (en) * 1992-06-30 1994-05-10 Pharmagroup International Optically active 5-oxygenated (3S)-1,3-dimethyloxindole-3-acetic acids
FR2694004B1 (fr) * 1992-07-21 1994-08-26 Adir Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
US5296478A (en) * 1992-10-07 1994-03-22 The Dupont Merck Pharmaceutical Co. 1-substituted oxindoles as cognition enhancers
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
US6147106A (en) * 1997-08-20 2000-11-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US6906093B2 (en) 1995-06-07 2005-06-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
RU2145852C1 (ru) * 1996-01-17 2000-02-27 Тайхо Фармасьютикал Ко., Лтд Ингибитор гипертрофии интимы, применение оксиндолового производного для получения ингибитора гипертрофии интимы, композиция для ингибирования гипертрофии интимы, способ предупреждения и лечения гипертрофии интимы
US20040067531A1 (en) * 1997-08-20 2004-04-08 Sugen, Inc. Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
US6531502B1 (en) * 1998-01-21 2003-03-11 Sugen, Inc. 3-Methylidenyl-2-indolinone modulators of protein kinase
KR20010101266A (ko) 1998-12-17 2001-11-14 프리돌린 클라우스너, 롤란드 비. 보레르 Jnk 단백질 키나제의 억제제로서의 4-아릴옥신돌
CN1138773C (zh) * 1998-12-17 2004-02-18 霍夫曼-拉罗奇有限公司 4-链烯基(和炔基)氧吲哚作为细胞周期蛋白-依赖性激酶尤其是cdk2的抑制剂
JP2002532503A (ja) 1998-12-17 2002-10-02 エフ.ホフマン−ラ ロシュ アーゲー プロテインキナーゼ阻害剤としての4,5−ピラジノオキシンドール
US6153634A (en) * 1998-12-17 2000-11-28 Hoffmann-La Roche Inc. 4,5-azolo-oxindoles
US6689806B1 (en) * 1999-03-24 2004-02-10 Sugen, Inc. Indolinone compounds as kinase inhibitors
US6313310B1 (en) 1999-12-15 2001-11-06 Hoffmann-La Roche Inc. 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
EP1251862B1 (de) * 2000-01-18 2008-10-01 Merck & Co., Inc. Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension
SK287142B6 (sk) 2000-02-15 2010-01-07 Sugen, Inc. Inhibítory proteínkináz na báze pyrolom substituovaného 2-indolinónu, farmaceutický prípravok s ich obsahom a ich použitie
FR2807038B1 (fr) * 2000-04-03 2002-08-16 Sanofi Synthelabo Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant
US6504034B2 (en) 2001-01-23 2003-01-07 Hoffmann-La Roche Inc. Naphthostyrils
AR042586A1 (es) 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
EP1434774A1 (de) 2001-10-10 2004-07-07 Sugen, Inc. 3-(4-substituierte heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivate als protein-kinase-inhibitoren
RS51204B (sr) 2005-02-07 2010-12-31 F. Hoffmann-La Roche Ag. Heterociklični supstituisani fenil metanoni kao inhibitori glicin transportera 1
WO2006105795A1 (en) * 2005-04-08 2006-10-12 Leo Pharma A/S Novel indolinone derivatives
MY145694A (en) 2005-04-11 2012-03-30 Xenon Pharmaceuticals Inc Spiroheterocyclic compounds and their uses as therapeutic agents
MY144968A (en) 2005-04-11 2011-11-30 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
JP5460324B2 (ja) 2006-10-12 2014-04-02 ゼノン・ファーマシューティカルズ・インコーポレイテッド 治療剤としてのスピロ−オキシインドール化合物の使用
DK2350090T3 (en) 2008-10-17 2015-09-07 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their use as therapeutic agents
EP2350091B1 (de) 2008-10-17 2015-06-03 Xenon Pharmaceuticals Inc. Spiro-oxindol verbindungen und ihre verwendung als therapeutische wirkstoffe
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
WO2011047174A1 (en) 2009-10-14 2011-04-21 Xenon Pharmaceuticals Inc. Synthetic methods for spiro-oxindole compounds
US9504671B2 (en) 2010-02-26 2016-11-29 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
US9682033B2 (en) 2015-02-05 2017-06-20 Teva Pharmaceuticals International Gmbh Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
CN106946759B (zh) * 2017-03-22 2020-02-14 中南大学 2-吲哚酮衍生物及其开环衍生物及合成方法与用途
CN114957084B (zh) * 2022-01-21 2023-05-09 九江学院 一种吲哚酮类化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3428649A (en) * 1968-01-23 1969-02-18 Mcneilab Inc Oxindole derivatives
DE3114351A1 (de) * 1981-04-09 1982-11-04 Hoechst Ag, 6000 Frankfurt "oxindol-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung"

Also Published As

Publication number Publication date
EP0429685B1 (de) 1997-10-29
KR930011300B1 (ko) 1993-11-29
DE69031649T2 (de) 1998-02-26
AU6032190A (en) 1991-02-22
EP0429685A4 (en) 1991-12-04
ATE159718T1 (de) 1997-11-15
JP2739188B2 (ja) 1998-04-08
US5206261A (en) 1993-04-27
KR920701153A (ko) 1992-08-11
DK0429685T3 (da) 1997-12-15
CA2037923C (en) 1996-08-06
ES2110965T3 (es) 1998-03-01
AU617621B2 (en) 1991-11-28
WO1991001306A1 (fr) 1991-02-07
CA2037923A1 (en) 1991-01-26
EP0429685A1 (de) 1991-06-05

Similar Documents

Publication Publication Date Title
DE69031649D1 (de) Oxoindolderivate
GB9423968D0 (en) Resolution
DK0524495T3 (da) Fremgangsmåde til fremstilling af pyranoner og pyrandioner
DK0629609T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamidderivater og et mellemprodukt dertil
NO166589C (no) Selv-tverrbindbar akrylpolymerer.
BR9200219A (pt) Composto 1-(2-piridil)pirazois,processo para suas preparacoes,composicoes pesticidas e metodo para controlar artropodes,nematodes,helmintas ou protozoarios
PT95852A (pt) Processo para a preparacao de agentes hipoglicemicos de oxazolidinediona
HU904187D0 (de)
DK199388A (da) Sulfonyldecahydro-8h-isoquino-oe2,1-gaaoe1,6aa-naphthyridiner, optiske isomerer deraf og beslaegtede forbindelser
IT1215298B (it) 2-(eteroalchil)-1,4-diidropiridine ed un processo per la loro produzione.
GR3020488T3 (en) Benzo(b)thiophene-2-carboxamides for the treatment of disorders of the central nervous system
ES2083568T3 (es) Derivado de biciclolactama.
YU168491A (sh) 8-azabiciklo/3,2,1/oktilalkiltiazolidinoli in postopek za njihovo pripravo
HU905000D0 (en) Process for producing compounds suitable for treatment of gastric ulcer
FI923744A0 (fi) Foerfarande och mellanprodukter foer framstaellning av 6-fluorbensisotiazoler.
DE3362036D1 (en) Ketene-o,o-acetates and process for their preparation
ATE119161T1 (de) Diazabicycloalkan-derivate.
ATE28876T1 (de) Triorganozinnacetylsalicylate und diese enthaltende biozide mittel.
DK561389D0 (da) Hukommelsesforbedrende midler indeholdende dioxopiperidinderivater
TH5307EX (th) สารฆ่าวัชพืชชนิดเฮเทอโรไซคลิค

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee